Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples